UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000017596
Receipt number R000020384
Scientific Title Retinal imaging (Spectral-domain Optical coherence tomography; SD-OCT) in Parkinson disease
Date of disclosure of the study information 2015/07/01
Last modified on 2017/05/17 10:16:22

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Retinal imaging (Spectral-domain Optical coherence tomography; SD-OCT) in Parkinson disease

Acronym

Retinal imaging in Parkinson disease

Scientific Title

Retinal imaging (Spectral-domain Optical coherence tomography; SD-OCT) in Parkinson disease

Scientific Title:Acronym

Retinal imaging in Parkinson disease

Region

Japan


Condition

Condition

Parkinson disease

Classification by specialty

Neurology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To examine the validity of retinal imaging (Spectral-domain Optical coherence tomography; SD-OCT) in Parkinson disease patients

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1

Exploratory

Trial characteristics_2

Pragmatic

Developmental phase

Not applicable


Assessment

Primary outcomes

The thinning of inner plexiform layer (IPL) and inner nuclear layer (INL) in the retina of Parkinson disease patients (compared to age matched healthy control)

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

No treatment

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Diagnosis

Type of intervention

Other

Interventions/Control_1

Spectral-domain Optical coherence tomography (SD-OCT)

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

40 years-old <=

Age-upper limit

75 years-old >

Gender

Male and Female

Key inclusion criteria

Idiopathic Parkinson disease (PD) patients who meet the United Kingdom brain bank criteria for idiopathic PD

Key exclusion criteria

(1) Cognitively abnormal PD patients and controls (diagnosed by Mini-Mental State Examinaion (MMSE) score under 20 points)
(2) PD patients and controls with any retinal pathological conditions, which effect on the results of the SD-OCT scan

Target sample size

100


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Kazushi Takahashi

Organization

Saitama Medical University

Division name

Department of Neurology

Zip code


Address

38 Morohongo, Moroyama-machi, Iruma-gun, Saitama-ken, Japan

TEL

049-276-1208

Email

tkazushi@saitama-med.ac.jp


Public contact

Name of contact person

1st name
Middle name
Last name Kazushi Takahashi

Organization

Saitama Medical University

Division name

Department of Neurology

Zip code


Address

38 Morohongo, Moroyama-machi, Iruma-gun, Saitama-ken, Japan

TEL

049-276-1208

Homepage URL


Email

tkazushi@saitama-med.ac.jp


Sponsor or person

Institute

Saitama Medical University Hospital

Institute

Department

Personal name



Funding Source

Organization

Grants-in-Aid for Scientific Research-KAKENHI

Organization

Division

Category of Funding Organization

Nationality of Funding Organization

JAPAN


Other related organizations

Co-sponsor

None

Name of secondary funder(s)

None


IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

埼玉医科大学病院(埼玉県),Saitama Medical University Hospital (Saitama-ken)


Other administrative information

Date of disclosure of the study information

2015 Year 07 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Terminated

Date of protocol fixation

2015 Year 05 Month 11 Day

Date of IRB


Anticipated trial start date

2015 Year 07 Month 01 Day

Last follow-up date

2017 Year 03 Month 31 Day

Date of closure to data entry

2017 Year 03 Month 31 Day

Date trial data considered complete

2017 Year 03 Month 31 Day

Date analysis concluded

2017 Year 03 Month 31 Day


Other

Other related information



Management information

Registered date

2015 Year 05 Month 16 Day

Last modified on

2017 Year 05 Month 17 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000020384


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name